137 related articles for article (PubMed ID: 36827075)
1. Identification and validation of the pyroptosis-related long noncoding rna signature to predict the prognosis of patients with bladder cancer.
Wu Z; Zeng J; Wu M; Liang Q; Li B; Hou G; Lin Z; Xu W
Medicine (Baltimore); 2023 Feb; 102(8):e33075. PubMed ID: 36827075
[TBL] [Abstract][Full Text] [Related]
2. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
Lu H; Wu J; Liang L; Wang X; Cai H
Front Immunol; 2022; 13():803355. PubMed ID: 35154117
[TBL] [Abstract][Full Text] [Related]
3. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
[TBL] [Abstract][Full Text] [Related]
4. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
5. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
[No Abstract] [Full Text] [Related]
6. Comprehensive analysis of the endoplasmic reticulum stress-related long non-coding RNA in bladder cancer.
Wu Z; Wang Y; Yan M; Liang Q; Li B; Hou G; Xia T; Lin Z; Xu W
Front Oncol; 2022; 12():951631. PubMed ID: 35992824
[TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of pyroptosis-related lncRNAs prediction model for bladder cancer.
Lia T; Shao Y; Regmi P; Li X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 35024796
[TBL] [Abstract][Full Text] [Related]
9. Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer.
Lu Z; Tang F; Li Z; Lai Y; Lu Z; Zhang J; Tang Z; Cai W; He Z
Dis Markers; 2022; 2022():7931393. PubMed ID: 35154513
[TBL] [Abstract][Full Text] [Related]
10. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
Zhang C; Li Z; Hu J; Qi F; Li X; Luo J
J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
12. m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer.
Feng ZH; Liang YP; Cen JJ; Yao HH; Lin HS; Li JY; Liang H; Wang Z; Deng Q; Cao JZ; Huang Y; Wei JH; Luo JH; Chen W; Chen ZH
J Transl Med; 2022 Oct; 20(1):492. PubMed ID: 36309694
[TBL] [Abstract][Full Text] [Related]
13. Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer.
Sun YF; Chen L; Xia QJ; Wang TH
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10217-10234. PubMed ID: 37269345
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
Front Genet; 2022; 13():838624. PubMed ID: 35928454
[TBL] [Abstract][Full Text] [Related]
15. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
[TBL] [Abstract][Full Text] [Related]
16. Identification of pyroptosis-related long non-coding RNAs with prognosis and therapy in lung squamous cell carcinoma.
Zhang Y; Wang Y; Yin X; Huang Y
Sci Rep; 2022 Jul; 12(1):11206. PubMed ID: 35778526
[TBL] [Abstract][Full Text] [Related]
17. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
[TBL] [Abstract][Full Text] [Related]
18. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
Tong H; Li T; Gao S; Yin H; Cao H; He W
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
[TBL] [Abstract][Full Text] [Related]
19. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
20. A pyroptosis-related lncRNA signature in bladder cancer.
Wang P; Wang Z; Zhu L; Sun Y; Castellano L; Stebbing J; Yu Z; Peng L
Cancer Med; 2023 Mar; 12(5):6348-6364. PubMed ID: 36237132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]